Evidence map›Paper›PMID 37324460›Full record

ArticleFrontiers in pharmacology2023

The dilemma of antibiotic susceptibility and clinical decision-making in a multi-drug-resistant

Long Chen, Xingyi Qu, Jingqian Su, Haijun Yao, Qiang Yuan, Yu Wang, Nanyang Li, Gang Wu, Xiaofen Liu, Jin Hu and 1 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Long ChenDepartment of Neurosurgery and Neurocritical Care, Huashan Hospital, Fudan University, Shanghai, China.
Xingyi QuFudan University and Key Laboratory of Clinical Pharmacology of Antibiotics and National Health Commission and National Clinical Research Center for Aging and Medicine, Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Jingqian SuFujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou, China.
Haijun YaoDepartment of Neurosurgery and Neurocritical Care, Huashan Hospital, Fudan University, Shanghai, China.
Qiang YuanDepartment of Neurosurgery and Neurocritical Care, Huashan Hospital, Fudan University, Shanghai, China.
Yu WangFudan University and Key Laboratory of Clinical Pharmacology of Antibiotics and National Health Commission and National Clinical Research Center for Aging and Medicine, Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Nanyang LiPhase I Unit, Huashan Hospital, Fudan University, Shanghai, China.
Gang WuDepartment of Neurosurgery and Neurocritical Care, Huashan Hospital, Fudan University, Shanghai, China.
Xiaofen LiuFudan University and Key Laboratory of Clinical Pharmacology of Antibiotics and National Health Commission and National Clinical Research Center for Aging and Medicine, Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Jin HuDepartment of Neurosurgery and Neurocritical Care, Huashan Hospital, Fudan University, Shanghai, China.
Jing ZhangFudan University and Key Laboratory of Clinical Pharmacology of Antibiotics and National Health Commission and National Clinical Research Center for Aging and Medicine, Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Fudan University · CNHuashan Hospital · CNFujian Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bloodstream infectionmultidisciplinary treatmentmulti-drug-resistant Pseudomonas aeruginosapharmacokinetics/pharmacodynamicstherapeutic drug monitoring

Identifiers

PMID37324460
PMCPMC10266203
OpenAlexW4378905559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.